Insights

Innovative Therapeutics Speranza Therapeutics has developed FDA-cleared medical devices such as the S.T. Genesis™ for opioid withdrawal, indicating a focus on clinically supported, high-demand treatment solutions that can be expanded through additional device and drug offerings.

Strategic Collaborations Recent partnerships with Sunshine Labs and StartEngine highlight the company’s commitment to advancing harm reduction strategies and attracting investment, creating opportunities to align product offerings with emerging market initiatives.

Focus on Orphan Drugs By distributing orphan drugs and medical devices for underserved chronic illnesses, Speranza presents a niche market with less competition, ideal for introducing specialized products tailored for specific patient populations.

Growth and Expansion Engagement in outcome-based care programs and strategic alliances positions Speranza for market growth, offering sales opportunities through healthcare providers seeking innovative treatment solutions for opioid dependency and related conditions.

Digital and Market Presence Active online engagement and a focus on clinical support services suggest opportunities to leverage digital channels and partnerships for targeted outreach to healthcare providers and treatment centers.

Similar companies to Speranza Therapeutics

Speranza Therapeutics Tech Stack

Speranza Therapeutics uses 8 technology products and services including Linkedin Insight Tag, W3 Total Cache, MySQL, and more. Explore Speranza Therapeutics's tech stack below.

Linkedin Insight Tag
Analytics
W3 Total Cache
Caching
MySQL
Database
oEmbed
Dev Tools
Font Awesome
Font Scripts
Priority Hints
Performance
Cloudflare Bot Management
Security
YouTube
Video Players

Media & News

Speranza Therapeutics's Email Address Formats

Speranza Therapeutics uses at least 1 format(s):

Speranza Therapeutics Email Formats	Example	Percentage
FLast@speranzatherapeutics.com	JDoe@speranzatherapeutics.com	41%
FirstLast@speranzatherapeutics.com	JohnDoe@speranzatherapeutics.com	9%
FLast@speranzatherapeutics.com	JDoe@speranzatherapeutics.com	41%
FirstLast@speranzatherapeutics.com	JohnDoe@speranzatherapeutics.com	9%

Frequently Asked Questions

Where is Speranza Therapeutics's headquarters located?

Speranza Therapeutics's main headquarters is located at 433 Plaza Real, #275. The company has employees across 1 continents, including North America.

What is Speranza Therapeutics's official website and social media links?

Speranza Therapeutics's official website is speranzatherapeutics.com and has social profiles on LinkedIn.

What is Speranza Therapeutics's SIC code NAICS code?

Speranza Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Speranza Therapeutics have currently?

As of December 2025, Speranza Therapeutics has approximately 15 employees across 1 continents, including North America. Key team members include Chief Financial Officer: J. B.Chief Technology Officer: S. K.Vice President Operations: W. S.. Explore Speranza Therapeutics's employee directory with LeadIQ.

What industry does Speranza Therapeutics belong to?

Speranza Therapeutics operates in the Biotechnology Research industry.

What technology does Speranza Therapeutics use?

Speranza Therapeutics's tech stack includes Linkedin Insight TagW3 Total CacheMySQLoEmbedFont AwesomePriority HintsCloudflare Bot ManagementYouTube.

What is Speranza Therapeutics's email format?

Speranza Therapeutics's email format typically follows the pattern of FLast@speranzatherapeutics.com. Find more Speranza Therapeutics email formats with LeadIQ.

When was Speranza Therapeutics founded?

Speranza Therapeutics was founded in 2020.

Speranza Therapeutics

Q: How many employees does Speranza Therapeutics have currently?

Speranza Therapeutics has approximately 15 employees.

Q: What technology does Speranza Therapeutics use?

Speranza Therapeutics's tech stack includes W3 Total Cache, Backbone.js, Lodash, Apache, Underscore.js.

Biotechnology ResearchFlorida, United States11-50 Employees

Speranza Therapeutics distributes and clinically supports orphan drugs and medical devices, creating options for patients whose chronic illnesses are not being effectively addressed.

Our guiding principle is simple - To remove the inherent challenges in delivering treatment to patients in need through proven, clinically effective therapeutics and technology.

S.T. Genesis™ is the first Speranza Therapeutics Innovation to hit the market. S.T. Genesis is an FDA-cleared Percutaneous Nerve Field Stimulator (PNFS), used as an aid to reduce the symptoms of opioid withdrawal. This powerful solution to the opioid crisis will partner with treatment centers, providing them with leading clinical technology, comprehensive protocols, patient support, and reimbursement services.

To learn more about Speranza Therapeutics and our products, please visit our website: http://speranzatherapeutics.com/

Company Overview

Headquarters: 433 Plaza Real, #275
Website: speranzatherapeutics.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2020
Employees: 11-50